Ascom (ASCN) Status Update summary

Leadership changes

• Michael Reitermann, with over 25 years of med-tech and life sciences experience, appointed as Delegate of the Board and interim CEO, succeeding Nicolas Vanden Abeele.

• An internal and external search for a permanent CEO has commenced.

• Laurent Dubois, Board member since 2020, nominated as new Chairman to be elected at the 2026 AGM, following Dr. Valentin Chapero Rueda's retirement.

• Board size to be reduced from six to five members effective at the 2026 AGM.

Strategic focus and operational direction

• Current strategy execution to be accelerated, with a special focus on growth in the USA and Canada.

• Michael Reitermann brings significant leadership experience from Siemens Medical Solutions and Siemens Healthineers.

• Laurent Dubois has extensive leadership experience in industry, consulting, and healthcare, including roles at McKinsey & Co. and GE Healthcare.

Communication and investor relations

• A conference call for analysts and media is scheduled for 18 September 2025 at 09:00 CET.

• Contact details for investor relations and media provided for further inquiries.